A detailed history of Exor Capital LLP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Exor Capital LLP holds 26,503,526 shares of TEVA stock, worth $594 Million. This represents 14.79% of its overall portfolio holdings.

Number of Shares
26,503,526
Previous 26,462,600 0.15%
Holding current value
$594 Million
Previous $430 Million 11.06%
% of portfolio
14.79%
Previous 15.49%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$15.81 - $18.96 $647,040 - $775,956
40,926 Added 0.15%
26,503,526 $478 Million
Q2 2024

Aug 12, 2024

BUY
$12.78 - $17.4 $486,470 - $662,331
38,065 Added 0.14%
26,462,600 $430 Million
Q1 2024

May 15, 2024

SELL
$10.67 - $14.43 $85.7 Million - $116 Million
-8,033,121 Reduced 23.31%
26,424,535 $373 Million
Q4 2023

Feb 13, 2024

BUY
$8.12 - $10.63 $4.94 Million - $6.46 Million
607,800 Added 1.8%
34,457,656 $360 Million
Q3 2023

Nov 13, 2023

BUY
$7.48 - $10.7 $72.1 Million - $103 Million
9,636,595 Added 39.8%
33,849,856 $345 Million
Q2 2023

Aug 11, 2023

BUY
$7.2 - $9.47 $51.3 Million - $67.4 Million
7,121,351 Added 41.67%
24,213,261 $182 Million
Q1 2023

May 15, 2023

BUY
$8.36 - $11.37 $17.4 Million - $23.7 Million
2,083,521 Added 13.88%
17,091,910 $151 Million
Q3 2022

Nov 07, 2022

BUY
$6.86 - $11.95 $79 Million - $138 Million
11,522,187 New
11,522,187 $93 Million
Q4 2021

Feb 14, 2023

BUY
$7.9 - $10.19 $27.5 Million - $35.5 Million
3,486,202 Added 30.26%
15,008,389 $120 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.9B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Exor Capital LLP Portfolio

Follow Exor Capital LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exor Capital LLP, based on Form 13F filings with the SEC.

News

Stay updated on Exor Capital LLP with notifications on news.